These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 32877694)
1. Scoparone as a therapeutic drug in liver diseases: Pharmacology, pharmacokinetics and molecular mechanisms of action. Hui Y; Wang X; Yu Z; Fan X; Cui B; Zhao T; Mao L; Feng H; Lin L; Yu Q; Zhang J; Wang B; Chen X; Zhao X; Sun C Pharmacol Res; 2020 Oct; 160():105170. PubMed ID: 32877694 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic mechanism of Yīn-Chén-Hāo decoction in hepatic diseases. Li JY; Cao HY; Sun L; Sun RF; Wu C; Bian YQ; Dong S; Liu P; Sun MY World J Gastroenterol; 2017 Feb; 23(7):1125-1138. PubMed ID: 28275293 [TBL] [Abstract][Full Text] [Related]
3. Recent progress in the study of Artemisiae Scopariae Herba (Yin Chen), a promising medicinal herb for liver diseases. Cai Y; Zheng Q; Sun R; Wu J; Li X; Liu R Biomed Pharmacother; 2020 Oct; 130():110513. PubMed ID: 32702631 [TBL] [Abstract][Full Text] [Related]
4. Scoparone alleviates inflammation, apoptosis and fibrosis of non-alcoholic steatohepatitis by suppressing the TLR4/NF-κB signaling pathway in mice. Liu B; Deng X; Jiang Q; Li G; Zhang J; Zhang N; Xin S; Xu K Int Immunopharmacol; 2019 Oct; 75():105797. PubMed ID: 31421545 [TBL] [Abstract][Full Text] [Related]
5. Metabolism of Scoparone in Experimental Animals and Humans. Juvonen RO; Novák F; Emmanouilidou E; Auriola S; Timonen J; Heikkinen AT; Küblbeck J; Finel M; Raunio H Planta Med; 2019 Apr; 85(6):453-464. PubMed ID: 30736072 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of bicyclol in liver diseases: Lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine. Zhao T; Mao L; Yu Z; Hui Y; Feng H; Wang X; Lin L; Fan X; Chen X; Wang B; Cao X; Sun C Int Immunopharmacol; 2021 Feb; 91():107308. PubMed ID: 33383448 [TBL] [Abstract][Full Text] [Related]
7. Promising traditional Chinese medicine for the treatment of cholestatic liver disease process (cholestasis, hepatitis, liver fibrosis, liver cirrhosis). Wei C; Qiu J; Wu Y; Chen Z; Yu Z; Huang Z; Yang K; Hu H; Liu F J Ethnopharmacol; 2022 Oct; 297():115550. PubMed ID: 35863612 [TBL] [Abstract][Full Text] [Related]
8. The Pharmacological Effects and Pharmacokinetics of Active Compounds of Hsueh TP; Lin WL; Dalley JW; Tsai TH Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680529 [No Abstract] [Full Text] [Related]
9. Pseudotargeted lipidomics analysis of scoparone on glycerophospholipid metabolism in non-alcoholic steatohepatitis mice by LC-MRM-MS. Song Q; Zhao Z; Liu H; Zhang J; Wang Z; Zhang Y; Ma G; Ge S PeerJ; 2024; 12():e17380. PubMed ID: 38799063 [TBL] [Abstract][Full Text] [Related]
10. Insight into the metabolic mechanism of scoparone on biomarkers for inhibiting Yanghuang syndrome. Fang H; Zhang A; Yu J; Wang L; Liu C; Zhou X; Sun H; Song Q; Wang X Sci Rep; 2016 Nov; 6():37519. PubMed ID: 27869223 [TBL] [Abstract][Full Text] [Related]
11. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula. Li H J Ethnopharmacol; 2020 Apr; 251():112442. PubMed ID: 31891799 [TBL] [Abstract][Full Text] [Related]
12. Preclinical Pharmacokinetics of Scoparone, Geniposide and Rhein in an Herbal Medicine Using a Validated LC-MS/MS Method. Hsueh TP; Tsai TH Molecules; 2018 Oct; 23(10):. PubMed ID: 30360359 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and tissue distribution study of scoparone in rats by ultraperformance liquid-chromatography with tandem high-definition mass spectrometry. Yin Q; Sun H; Zhang A; Wang X Fitoterapia; 2012 Jun; 83(4):795-800. PubMed ID: 22465507 [TBL] [Abstract][Full Text] [Related]
14. Comparison of In Vitro Hepatic Scoparone 7-O-Demethylation between Humans and Experimental Animals. Fayyaz A; Makwinja S; Auriola S; Raunio H; Juvonen RO Planta Med; 2018 Mar; 84(5):320-328. PubMed ID: 28950382 [TBL] [Abstract][Full Text] [Related]
15. Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages. Liu B; Deng X; Jiang Q; Li G; Zhang J; Zhang N; Xin S; Xu K Biomed Pharmacother; 2020 May; 125():109895. PubMed ID: 32000066 [TBL] [Abstract][Full Text] [Related]
16. Aqueous extract of Yin-Chen-Hao decoction, a traditional Chinese prescription, exerts protective effects on concanavalin A-induced hepatitis in mice through inhibition of NF-kappaB. Cai H; Song YH; Xia WJ; Jin MW J Pharm Pharmacol; 2006 May; 58(5):677-84. PubMed ID: 16640837 [TBL] [Abstract][Full Text] [Related]
17. Recent Studies and Progression of Yin Chen Hao ( Yīn Chén Hāo), a Long-term Used Traditional Chinese Medicine. Hung HY; Kuo SC J Tradit Complement Med; 2013 Jan; 3(1):2-6. PubMed ID: 24716150 [TBL] [Abstract][Full Text] [Related]
18. Comparative Pharmacokinetics of Scoparone and its Metabolite Scopoletin in Normal and ANIT-induced Intrahepatic Cholestatic Rats. Tian Q; Jin H; Huo X; Zhao Y; Wu W; Xu L; Wang Y; Yang X; Sun C; Deng S; Shu X Curr Drug Metab; 2023; 24(4):303-311. PubMed ID: 37165497 [TBL] [Abstract][Full Text] [Related]
19. Scoparone attenuates angiotensin II-induced extracellular matrix remodeling in cardiac fibroblasts. Fu B; Su Y; Ma X; Mu C; Yu F J Pharmacol Sci; 2018 Jun; 137(2):110-115. PubMed ID: 29921497 [TBL] [Abstract][Full Text] [Related]
20. Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice. Li S; Qian Y; Xie R; Li Y; Jia Z; Zhang Z; Huang R; Tuo L; Quan Y; Yu Z; Liu J; Xiang M J Ethnopharmacol; 2019 Oct; 242():112029. PubMed ID: 31216433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]